- Hem
- Om universitetet
- Hitta person
- Erik Pålsson
Erik Pålsson
Forskningsrådgivare
Sahlgrenska akademins kansliOm Erik Pålsson
Erik Pålsson arbetar som forskningsrådgivare vid Avdelningen för forskningsstöd, Sahlgrenska akademin. Hans huvudsakliga arbetsuppgifter är att ge stöd till forskare i att identifiera finansieringsmöjligheter och utforma ansökningar om forskningsbidrag. Erik arbetar också med Avdelningen för forskningsstöds kursverksamhet inom Grant Writing och stöd till forskare inom områdena forskningsetik och kliniska studier. Slutligen har Erik ett tidsbegränsat uppdrag som handledare och projektledare i Mikael Landéns forskargrupp vid Institutionen för neurovetenskap och fysiologi.
-
The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment: Response to
Mattes.
Hemen Najar, Erik Pålsson, Mikael Landén
The American journal of psychiatry - 2024 -
Altered brain dopamine metabolism is a trait marker for bipolar
disorder
Erik Pålsson, Carl Sellgren, Aurimantas Pelanis, Henrik Zetterberg, Kaj Blennow, Mikael Landén
Biomarkers in Neuropsychiatry - 2023 -
Dissecting the impact of complement component 4A in bipolar
disorder.
Elin Hörbeck, Lina Jonsson, Susmita Malwade, Robert Karlsson, Erik Pålsson, Robert Sigström, Carl M Sellgren, Mikael Landén
Brain, behavior, and immunity - 2023 -
Alterations in the Serum Proteome Following Electroconvulsive Therapy for a Major Depressive Episode: A Longitudinal Multicenter
Study
Andreas Göteson, C. C. Clements, A. Juréus, Erik Joas, Jessica Holmén Larsson, R. Karlsson, A. Nordenskjöld, Erik Pålsson, Mikael Landén
Biological Psychiatry: Global Open Science - 2023 -
Time effect on cardiometabolic risk indicators in patients with bipolar disorder: a longitudinal case-control
study
Hemen Najar, Erik Joas, Erik Pålsson, Mikael Landén
European Archives of Psychiatry and Clinical Neuroscience - 2023 -
Cardiometabolic risk indicators in individuals with bipolar disorders: a replication
study
Hemen Najar, Alina (Aikaterini) Karanti, Erik Pålsson, Mikael Landén
Diabetology and Metabolic Syndrome - 2023 -
Ghrelin activates the mesolimbic dopamine system via nitric oxide associated mechanisms in the ventral tegmental
area
Jörgen Engel, Erik Pålsson, Daniel Vallöf, Elisabeth Jerlhag
Nitric Oxide-Biology and Chemistry - 2023 -
Metabolomics analysis of cerebrospinal fluid suggests citric acid cycle aberrations in bipolar
disorder
Erik Smedler, Alireza Salehi, Aurimantas Pelanis, Ana Andreazza, Erik Pålsson, Timea Sparding, Mikael Landén
Neuroscience Applied - 2022 -
Association Between Polygenic Risk Scores and Outcome of
ECT
Robert Sigström, Kaarina Kowalec, Lina Jonsson, Caitlin C Clements, Robert Karlsson, Axel Nordenskjöld, Erik Pålsson, Patrick F Sullivan, Mikael Landén
The American journal of psychiatry - 2022 -
A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar
disorder
Andreas Göteson, Anniella Isgren, Timea Sparding, Jessica Holmén Larsson, Joel Jakobsson, Erik Pålsson, Mikael Landén
Translational Psychiatry - 2022 -
Cohort profile: the Swedish National Quality Register for bipolar
disorder(BipolaR)
Erik Pålsson, L. Melchior, K. L. Sundel, Alina (Aikaterini) Karanti, Erik Joas, A. Nordenskjold, M. Agestam, B. Runeson, Mikael Landén
Bmj Open - 2022 -
Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery
study
Johan V Sandberg, Caroline Hansson, Andreas Göteson, Erik Joas, Joel Jakobsson, Erik Pålsson, Mikael Landén
Molecular Psychiatry - 2022 -
Patient educational level and management of bipolar
disorder
Alina (Aikaterini) Karanti, Lana Bublik, Mathias Kardell, Kristina Annerbrink, P. Lichtenstein, B. Runeson, Erik Pålsson, Mikael Landén
Bjpsych Open - 2021 -
Central levels of tryptophan metabolites in subjects with bipolar
disorder.
Ada Trepci, Carl M Sellgren, Erik Pålsson, Lena Brundin, Neda Khanlarkhani, Lilly Schwieler, Mikael Landén, Sophie Erhardt
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 2021 -
Characterisation of age and polarity at onset in bipolar
disorder
J. L. Kalman, L. M. O. Loohuis, A. Vreeker, A. McQuillin, E. A. Stahl, D. Ruderfer, M. Grigoroiu-Serbanescu, G. Panagiotaropoulou, S. Ripke, T. B. Bigdeli, F. Stein, T. Meller, S. Meinert, H. Pelin, F. Streit, S. Papiol, M. J. Adams, R. Adolfsson, K. Adorjan, I. Agartz, S. R. Aminoff, H. Anderson-Schmidt, O. A. Andreassen, R. Ardau, J. M. Aubry, C. Balaban, N. Bass, B. T. Baune, F. Bellivier, A. Benabarre, S. Bengesser, W. H. Berrettini, M. P. Boks, E. J. Bromet, K. Brosch, M. Budde, W. Byerley, P. Cervantes, C. Chillotti, S. Cichon, S. R. Clark, A. L. Comes, A. Corvin, W. Coryell, N. Craddock, D. W. Craig, P. E. Croarkin, C. Cruceanu, P. M. Czerski, N. Dalkner, U. Dannlowski, F. Degenhardt, M. Del Zompo, J. R. DePaulo, S. Djurovic, H. J. Edenberg, M. Al Eissa, T. Elvsashagen, B. Etain, A. H. Fanous, F. Fellendorf, A. Fiorentino, A. J. Forstner, M. A. Frye, J. M. Fullerton, K. Gade, J. Garnham, E. Gershon, M. Gill, F. S. Goes, K. Gordon-Smith, P. Grof, J. Guzman-Parra, T. Hahn, R. Hasler, M. Heilbronner, U. Heilbronner, S. Jamain, E. Jimenez, I. Jones, L. Jones, Lina Jonsson, R. S. Kahn, J. R. Kelsoe, J. L. Kennedy, T. Kircher, G. Kirov, S. Kittel-Schneider, F. Klohn-Saghatolislam, J. A. Knowles, T. M. Kranz, T. V. Lagerberg, Mikael Landén, W. B. Lawson, M. Leboyer, Q. Q. S. Li, M. Maj, D. Malaspina, M. Manchia, F. Mayoral, S. L. McElroy, M. G. McInnis, A. M. McIntosh, H. Medeiros, I. Melle, V. Milanova, P. B. Mitchell, P. Monteleone, A. M. Monteleone, M. M. Nothen, T. Novak, J. I. Nurnberger, N. O'Brien, K. S. O'Connell, C. O'Donovan, M. C. O'Donovan, N. Opel, A. Ortiz, M. J. Owen, Erik Pålsson, C. Pato, M. T. Pato, J. Pawlak, J. K. Pfarr, C. Pisanu, J. B. Potash, M. H. Rapaport, D. Reich-Erkelenz, A. Reif, E. Reininghaus, J. Repple, H. Richard-Lepouriel, M. Rietschel, K. Ringwald, G. Roberts, G. Rouleau, S. Schaupp, W. A. Scheftner, S. Schmitt, P. R. Schofield, K. O. Schubert, E. C. Schulte, B. Schweizer, F. Senner, G. Severino, S. Sharp, C. Slaney, O. B. Smeland, J. L. Sobell, A. Squassina, P. Stopkova, J. Strauss, A. Tortorella, G. Turecki, J. Twarowska-Hauser, M. Veldic, E. Vieta, J. B. Vincent, W. Xu, C. C. Zai, P. P. Zandi, A. Di Florio, J. W. Smoller, J. M. Biernacka, F. J. McMahon, M. Alda, B. Muller-Myhsok, N. Koutsouleris, P. Falkai, N. B. Freimer, T. F. M. Andlauer, T. G. Schulze, R. A. Ophoff
British Journal of Psychiatry - 2021 -
Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar
disorder
Andreas Göteson, Anniella Isgren, Lina Jonsson, Timea Sparding, Erik Smedler, Aurimantas Pelanis, Henrik Zetterberg, Joel Jakobsson, Erik Pålsson, Jessica Holmén Larsson, Mikael Landén
Molecular Psychiatry - 2021 -
Serum profiling of anorexia nervosa: A 1H NMR-based metabolomics
study.
Alireza Salehi M, Ida Ak Nilsson, João Figueira, Laura M Thornton, Israa Abdulkarim, Erik Pålsson, Cynthia M Bulik, Mikael Landén
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 2021 -
Regional lithium prescription rates and recurrence in bipolar
disorder
Martin Sköld, Sindre Rolstad, Erik Joas, Mathias Kardell, Erik Pålsson, G. M. Goodwin, Mikael Landén
International Journal of Bipolar Disorders - 2021 -
Influence of genetic variations in IL1B on brain region volumes in bipolar patients and
controls.
Nina Strenn, Erik Pålsson, Benny Liberg, Mikael Landén, Agneta Ekman
Psychiatry research - 2021 -
Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive
therapy
C. C. Clements, R. Karlsson, Y. Lu, A. Jureus, C. Ruck, E. Andersson, J. Boberg, N. L. Pedersen, C. M. Bulik, A. Nordenskjold, Erik Pålsson, P. F. Sullivan, Mikael Landén
Molecular Psychiatry - 2021 -
Long-term trajectory of cognitive performance in people with bipolar disorder and controls: 6-year longitudinal
study
Timea Sparding, Erik Joas, C. Clements, C. M. Sellgren, Erik Pålsson, Mikael Landén
Bjpsych Open - 2021 -
Characteristics of bipolar I and II disorder: A study of 8766
individuals.
Alina (Aikaterini) Karanti, Mathias Kardell, Erik Joas, Bo Runeson, Erik Pålsson, Mikael Landén
Bipolar disorders - 2020 -
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders
(Gen-ECT-ic)
T. Soda, D. M. McLoughlin, S. R. Clark, L. Oltedal, U. Kessler, J. Haavik, C. Bousman, D. J. Smith, M. Bioque, C. C. Clements, C. Loo, F. Vila-Rodriguez, A. Minelli, B. J. Mickey, R. Milev, A. R. Docherty, J. L. Martin, E. D. Achtyes, V. Arolt, R. Redlich, U. Dannlowski, N. Cardoner, E. Clare, N. Craddock, A. Di Florio, M. Dmitrzak-Weglarz, L. Forty, K. Gordon-Smith, M. Husain, W. M. Ingram, L. Jones, I. Jones, M. Juruena, G. Kirov, Mikael Landén, D. J. Muller, A. Nordenskold, Erik Pålsson, M. Paul, A. Permoda, B. Pliszka, J. Rea, K. O. Schubert, J. A. Sonnen, V. Soria, W. Stageman, A. Takamiya, M. Urretavizacaya, S. Watson, M. Zavorotny, A. H. Young, E. Vieta, J. K. Rybakowski, M. Gennarelli, P. P. Zandi, P. F. Sullivan, B. T. Baune
European Archives of Psychiatry and Clinical Neuroscience - 2020 -
Psychoeducation for bipolar disorder and risk of recurrence and hospitalization - a within-individual analysis using registry
data.
Erik Joas, Kristoffer Bäckman, Alina (Aikaterini) Karanti, Timea Sparding, Francesc Colom, Erik Pålsson, Mikael Landén
Psychological medicine - 2020 -
Long-term subjective memory after electroconvulsive
therapy.
Robert Sigström, Axel Nordenskjöld, Anders Juréus, Caitlin Clements, Erik Joas, Erik Pålsson, Mikael Landén
BJPsych open - 2020 -
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK
initiative
J. Scott, D. Hidalgo-Mazzei, R. Strawbridge, A. Young, M. Resche-Rigon, B. Etain, O. A. Andreassen, M. Bauer, D. Bennabi, A. M. Blamire, F. Boumezbeur, P. Brambilla, N. Cattane, A. Cattaneo, M. Chupin, K. Coello, Y. Cointepas, F. Colom, D. A. Cousins, C. Dubertret, E. Duchesnay, A. Ferro, A. Garcia-Estela, J. Goikolea, A. Grigis, E. Haffen, M. C. Hoegh, P. Jakobsen, J. L. Kalman, L. V. Kessing, F. Klohn-Saghatolislam, T. V. Lagerberg, Mikael Landén, U. Lewitzka, A. Lutticke, N. Mazer, M. Mazzelli, C. Mora, T. Muller, E. Mur-Mila, K. J. Oedegaard, L. Oltedal, Erik Pålsson, D. P. Orfanos, S. Papiol, V. Perez-Sola, A. Reif, P. Ritter, R. Rossi, T. Schulze, F. Senner, F. E. Smith, L. Squarcina, N. E. Steen, P. E. Thelwall, C. Varo, E. Vieta, M. Vinberg, M. Wessa, L. T. Westlye, F. Bellivier
International Journal of Bipolar Disorders - 2019 -
CACNA1C polymorphism and brain cortical structure in bipolar
disorder
Erik Smedler, Christoph Abé, Erik Pålsson, Martin Ingvar, Mikael Landén
Journal of psychiatry & neuroscience : JPN - 2019 -
Risk factors for suicide in bipolar disorder: a cohort study of 12 850
patients
Caroline Hansson, Erik Joas, Erik Pålsson, K. Hawton, B. Runeson, Mikael Landén
Acta Psychiatrica Scandinavica - 2018 -
Classification of cognitive performance in bipolar
disorder.
Timea Sparding, Katja Silander, Erik Pålsson, Josefin Östlind, Carl Johan Ekman, Carl M Sellgren, Erik Joas, Stefan Hansen, Mikael Landén
Cognitive neuropsychiatry - 2017 -
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and
controls.
Erik Pålsson, Carl Sellgren, Eleonore Rydén, Ruth Kizza, Aurimantas Pelanis, Henrik Zetterberg, Kaj Blennow, Mikael Landén
Journal of neural transmission (Vienna, Austria : 1996) - 2017 -
Personality traits in bipolar disorder and influence on
outcome.
Timea Sparding, Erik Pålsson, Erik Joas, Stefan Hansen, Mikael Landén
BMC psychiatry - 2017 -
Weight gain with add-on second-generation antipsychotics in bipolar disorder: a naturalistic
study
Hemen Najar, Erik Joas, Mathias Kardell, Erik Pålsson, Mikael Landén
Acta Psychiatrica Scandinavica - 2017 -
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and
neuroinflammation
L. Brundin, C. M. Sellgren, C. K. Lim, J. Grit, Erik Pålsson, Mikael Landén, M. Samuelsson, K. Lundgren, P. Brundin, D. Fuchs, T. T. Postolache, L. Traskman-Bendz, G. J. Guillemin, S. Erhardt
Translational Psychiatry - 2016 -
Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar
disorder.
Noriko Yoshimi, Takashi Futamura, Keiji Kakumoto, Alireza M Salehi, Carl M Sellgren, Jessica Holmén Larsson, Joel Jakobsson, Erik Pålsson, Mikael Landén, Kenji Hashimoto
BBA clinical - 2016 -
Polymorphisms of BDNF and CACNA1C are not associated with cognitive functioning in bipolar disorder or healthy
controls.
Sindre Rolstad, Carl Sellgren Majkowitz, Erik Joas, Carl Johan Ekman, Erik Pålsson, Mikael Landén
Cognitive neuropsychiatry - 2016 -
CACNA1C polymorphism and altered phosphorylation of tau in bipolar
disorder.
Joel Jakobsson, Erik Pålsson, Carl Sellgren, Frida Rydberg, Agneta Ekman, Henrik Zetterberg, Kaj Blennow, Mikael Landén
The British journal of psychiatry : the journal of mental science - 2016 -
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction
hypothesis
N. Yoshimi, T. Futamura, S. E. Bergen, Y. Iwayama, T. Ishima, C. Sellgren, C. J. Ekman, Joel Jakobsson, Erik Pålsson, K. Kakumoto, Y. Ohgi, T. Yoshikawa, Mikael Landén, K. Hashimoto, Welches O. R. V. P. G
Molecular Psychiatry - 2016 -
Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary
syndrome.
Ingrid Larsson, Lena Hulthén, Mikael Landén, Erik Pålsson, Per-Olof Janson, Elisabet Stener-Victorin
Clinical nutrition (Edinburgh, Scotland) - 2016 -
Increased brain nitric oxide levels following ethanol
administration
N. Finnerty, S. L. O'Riordan, Daniel Klamer, J. Lowry, Erik Pålsson
Nitric oxide - 2015 -
Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar
disorder
Sindre Rolstad, Erik Pålsson, Carl Johan Ekman, Elias Eriksson, Carl Sellgren, Mikael Landén
Bipolar disorders - 2015 -
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic
treatment.
Anniella Isgren, Joel Jakobsson, Erik Pålsson, Carl Johan Ekman, Anette G M Johansson, Carl Sellgren, Kaj Blennow, Henrik Zetterberg, Mikael Landén
Brain, behavior, and immunity - 2015 -
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive
impairment.
Sindre Rolstad, Joel Jakobsson, Carl Sellgren, Anniella Isgren, Carl Johan Ekman, Maria Bjerke, Kaj Blennow, Henrik Zetterberg, Erik Pålsson, Mikael Landén
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 2015 -
Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy
Controls
Sindre Rolstad, Joel Jakobsson, C. Sellgren, C. J. Ekman, Kaj Blennow, Henrik Zetterberg, Erik Pålsson, Mikael Landén
Plos One - 2015 -
Monocyte and microglial activation in patients with mood-stabilized bipolar
disorder.
Joel Jakobsson, Maria Bjerke, Sara Sahebi, Anniella Isgren, Carl Johan Ekman, Carl Sellgren, Bob Olsson, Henrik Zetterberg, Kaj Blennow, Erik Pålsson, Mikael Landén
Journal of psychiatry & neuroscience : JPN - 2015 -
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy
controls
Erik Pålsson, Joel Jakobsson, Kristoffer Södersten, Y. Fujita, C. Sellgren, C. J. Ekman, Hans Ågren, K. Hashimoto, Mikael Landén
European Neuropsychopharmacology - 2015 -
Cognitive Functioning in Clinically Stable Patients with Bipolar Disorder I and
II
Timea Sparding, Katja Silander, Erik Pålsson, Josefin Östlind, C. Sellgren, C. J. Ekman, Erik Joas, Stefan Hansen, Mikael Landén
Plos One - 2015 -
Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide
attempts.
Johan V Sandberg, Joel Jakobsson, Erik Pålsson, Mikael Landén, Aleksander A Mathé
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 2014 -
Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent
cohorts.
Kristoffer Södersten, Erik Pålsson, Tamaki Ishima, Keiko Funa, Mikael Landén, Kenji Hashimoto, Hans Ågren
Journal of affective disorders - 2014 -
Apolipoprotein e genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer
disease.
Ronald Lautner, Sebastian Palmqvist, Niklas Mattsson, Ulf Andreasson, Anders Wallin, Erik Pålsson, Joel Jakobsson, Sanna-Kaisa Herukka, Rikard Owenius, Bob Olsson, Harald Hampel, Dan Rujescu, Michael Ewers, Mikael Landén, Lennart Minthon, Kaj Blennow, Henrik Zetterberg, Oskar Hansson
JAMA psychiatry - 2014 -
Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic
treatment
Henrik Zetterberg, Joel Jakobsson, Mikael Redsäter, Ulf Andreasson, Erik Pålsson, C. J. Ekman, C. Sellgren, A. G. M. Johansson, Kaj Blennow, Mikael Landén
Psychiatry Research - 2014 -
Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched
controls
Erik Pålsson, Clara Figueras, Anette GM Johansson, Carl-Johan Ekman, Björn Hultman, Josefin Östlind, Mikael Landén
BMC Psychiatry - 2013 -
An Investigation of Hypofrontality in an Animal Model of Schizophrenia Using Real-Time Microelectrochemical Sensors for Glucose, Oxygen, and Nitric
Oxide
N. J. Finnerty, F. B. Bolger, Erik Pålsson, J. P. Lowry
Acs Chemical Neuroscience - 2013 -
Brain nitric oxide: Regional characterisation of a real-time microelectrochemical
sensor
N. J. Finnerty, S. L. O'Riordan, Erik Pålsson, J. P. Lowry
Journal of Neuroscience Methods - 2012 -
L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot
study.
Caroline Wass, Daniel Klamer, Evangelos Katsarogiannis, Erik Pålsson, Lennart Svensson, Kim Fejgin, Inga-Britt Bogren, Jörgen Engel, Birgitta Rembeck
BMC medicine - 2011 -
Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information
processing.
Daniel Klamer, Lennart Svensson, Kim Fejgin, Erik Pålsson
European Neuropsychopharmacology - 2011 -
Information processing deficits and nitric oxide signalling in the phencyclidine model of
schizophrenia.
Erik Pålsson, John Lowry, Daniel Klamer
Psychopharmacology - 2010 -
Noise benefit in prepulse inhibition of the acoustic startle
reflex.
Erik Pålsson, Göran Söderlund, Daniel Klamer, Filip Bergquist
Psychopharmacology - 2010 -
Increased cortical nitric oxide release after phencyclidine
administration.
Erik Pålsson, Niall Finnerty, Kim Fejgin, Daniel Klamer, Caroline Wass, Lennart Svensson, John Lowry
Synapse (New York, N.Y.) - 2009 -
Prefrontal GABA(B) Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric
Oxide.
Kim Fejgin, Erik Pålsson, Caroline Wass, Niall Finnerty, John Lowry, Daniel Klamer
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 2009 -
The importance of nitric oxide in social
dysfunction.
Caroline Wass, Daniel Klamer, Kim Fejgin, Erik Pålsson
Behavioural brain research - 2009 -
Ethanol increases brain nitric oxide levels in
rats
Erik Pålsson, Niall Finnerty, Kim Fejgin, Finbar Brown, Daniel Klamer, Lennart Svensson, John P Lowry
Presented at EWCBR. March, 2008, Les Arcs, France - 2008 -
Nitric oxide and GABAB-sensitive mechanisms in the prefrontal cortex are important for the disruptive effects of phencyclidine on prepulse
inhibition
Kim Fejgin, Erik Pålsson, Caroline Wass, Jörgen Engel, Lennart Svensson, Daniel Klamer
Presented at Cognitive Dysfunctions in Disease: Mechanisms and Therapies. April 2008, Stockholm, Sweden, - 2008 -
Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of
phencyclidine.
Kim Fejgin, Erik Pålsson, Caroline Wass, Lennart Svensson, Daniel Klamer
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 2008 -
Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive
flexibility.
Caroline Wass, Lennart Svensson, Kim Fejgin, Erik Pålsson, Trevor Archer, Jörgen Engel, Daniel Klamer
Pharmacology, biochemistry, and behavior - 2008 -
Systemic adminstration of Phencyclidine increases Nitric oxide levels in the rat medial prefrontal
cortex
Daniel Klamer, Kim Fejgin, Erik Pålsson, Niall J Finnerty, Caroline Wass, Jörgen Engel, Lennart Svensson, John P Lowry
Presented at EWCBR. March, 2008, Les Arcs, France - 2008 -
Cognitive dysfunctions in schizophrenia: focus on the nitric oxide pathway in rodent
models
Daniel Klamer, Kim Fejgin, Caroline Wass, Niall J Finnerty, John P Lowry, Jörgen Engel, Lennart Svensson, Erik Pålsson
Presented at Cognitive Dysfunctions in Disease: Mechanisms and Therapies. Stockholm, Sweden. April 2008 - 2008 -
Agmatine attenuates the disruptive effects of phencyclidine on prepulse
inhibition.
Erik Pålsson, Kim Fejgin, Caroline Wass, Daniel Klamer
European journal of pharmacology - 2008 -
The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in
mice.
Erik Pålsson, Kim Fejgin, Caroline Wass, Jörgen Engel, Lennart Svensson, Daniel Klamer
Psychopharmacology - 2007 -
The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in
mice.
Kim Fejgin, Sergej Safonov, Erik Pålsson, Caroline Wass, Jörgen Engel, Lennart Svensson, Daniel Klamer
Psychopharmacology - 2007 -
Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference
memory
Caroline Wass, Trevor Archer, Erik Pålsson, Kim Fejgin, A. Alexandersson, Daniel Klamer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2006 -
Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent
mechanisms
Caroline Wass, Trevor Archer, Erik Pålsson, Kim Fejgin, Daniel Klamer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2006 -
Cognitive function studied in animal models of
schizophrenia
Erik Pålsson
2006 -
Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion
conditioning
Daniel Klamer, Erik Pålsson, Caroline Wass, Trevor Archer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2005 -
The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and
conditioning
Erik Pålsson, Daniel Klamer, Caroline Wass, Trevor Archer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2005 -
Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse
inhibition
Daniel Klamer, Erik Pålsson, Kim Fejgin, J. Zhang, Jörgen Engel, Lennart Svensson
Psychopharmacology (Berl) - 2005 -
Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory
mechanisms
Daniel Klamer, Erik Pålsson, Aron Revesz, Jörgen Engel, Lennart Svensson
Psychopharmacology (Berl) - 2004